| 【Company Research】Zhejiang Dingli - A (603338 CH) – Satisfactory results in 2Q; Negatives priced in; U/G to BUY |
| 【公司研究】奈雪的茶 (2150 HK) – 公司运营的结构性改善持续 |
| 【Company Research】Razer Inc. (1337 HK) – Core business continued its strong growth in 1H21 |
| 【Company Research】Willsemi (603501 CH) – The next chapter beyond mobile CIS is coming |
| 【Company Research】Tigermed (300347 CH) – Strong backlog growth driven by solid demand |
| 【Fixed Income Research】Greenland – Initial success in deleveraging promise |
| 【Company Research】CSPC Pharmaceutical (1093 HK) –1H21 results beat; accelerating BD pace |
| 【Fixed Income Research】REDSUN - Looking for opportunities in the kinked credit curve |
| 【Company Research】Innovent Biologics (1801 HK) – Building world-leading innovation platform |
| 【Company Research】China Life (2628 HK) – Focus on agency upgrade |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
